XML 81 R67.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation - Stock Option Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Number of Options    
Outstanding, beginning of period (in shares) 42,422,473  
Outstanding, end of period (in shares) 32,446,814 42,422,473
Stock options    
Number of Options    
Outstanding, beginning of period (in shares) 42,422,473  
Granted (in shares) 0  
Exercised (in shares) (7,650,525)  
Forfeited (in shares) (2,703,962)  
Assumed options from Attivo acquisition (in shares) 378,828  
Outstanding, end of period (in shares) 32,446,814 42,422,473
Expected to vest (in shares) 32,446,814  
Options, vested and exercisable, number (in shares) 19,645,571  
Weighted-Average Exercise Price    
Outstanding, beginning of period (in USD per share) $ 4.30  
Granted (in USD per share) 0  
Exercised (in USD per share) 2.26  
Forfeited (in USD per share) 4.68  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Acquired in Period, Weighted Average Exercise Price 1.31  
Outstanding, end of period (in USD per share) 4.71 $ 4.30
Expected to vest (in USD per shares) 4.71  
Options, vested and exercisable, weighted average exercise price (in USD per share) $ 3.54  
Weighted-Average Remaining Contractual Term (in years)    
Weighted-Average Remaining Contractual Term (in years), Outstanding 6 years 6 months 7 days 6 years 6 months
Expected to vest (in years) 6 years 6 months 7 days  
Weighted-Average Remaining Contractual Term (in years), Vested and exercisable (in years) 5 years 11 months 19 days  
Aggregate Intrinsic Value (in thousands)    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $ 337,214 $ 1,714,821
Expected to vest 337,214  
Vested and exercisable $ 227,200